查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571654

非血管支架市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分市场预测，2024-2030 年

Non-vascular Stents Market Size, Share & Trends Analysis Report By Type (Gastrointestinal Stents, Duodenal, Colonic, Pulmonary (Airway) Stents, Urological Stents), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

非血管支架市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球非血管支架市场规模将达22.7亿美元，2024年至2030年复合年增长率为4.8%。

由于非血管支架的技术进步和全球微创手术的日益普及，预计市场在预测期内将出现良好的成长。

放射性和生物分解性支架的市场开拓、先进支架设计和材料成分的变化以及超音波超音波引导（EUS）支架置入等新支架留置技术等技术进步预计将有助于支架市场的成长。有多种材料可供选择，包括由镍钛诺、硅胶和镍钛诺、不銹钢和Elgiloy（钴铬镍合金）等合金製成的金属支架，以及由树脂、聚氨酯等合成聚合物製成的非金属支架、和硅胶。

由于医疗保健专业人员对非血管支架置入术等微创技术的高采用率，预计该市场将会成长。这是由于各种好处，例如切口更小、创伤治疗更快、疼痛和手术疤痕减少。较小的切口和手术伤口可减少併发症并显着降低整体手术成本。此外，微创手术可以缩短住院时间，进而降低病患发生院内感染的风险。这可以减少患者的整体医疗保健支出。

非血管支架市场报告亮点

  • 由于胆管癌和胆结石等肝臟和胆管疾病的发生率不断增加，以及对解决阻塞问题的微创方法的需求不断增长，2023年市场将由胆管支架主导。
  • 由于食道、胃癌、胆囊、小肠、胰臟、肝癌、肠癌和肛门等胃肠道癌症患者数量迅速增加，预计胃肠道支架细分市场在预测期内将出现最高增长。
  • 由于主要市场参与者在当地的存在、强大的医疗基础设施以及美国和加拿大胃肠道癌症的高盛行率，预计北美将在预测期内主导市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球非血管支架市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 全球非血管支架市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 全球非血管支架市场：产品预估及趋势分析

  • 细分仪表板
  • 非血管支架市场：2023 年和 2030 年产品变化分析
  • 胃肠支架
  • 胆道
  • 十二指肠
  • 冒号
  • 胰臟
  • 食道支架
  • 肺（气道）支架
  • 硅胶气道
  • 金属气道
  • 泌尿系统支架

第五章全球非血管支架市场：最终用途估算与趋势分析

  • 细分仪表板
  • 非血管支架市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 门诊护理中心 (ACS)
  • 专科诊所

第六章 全球非血管支架市场：区域估算及趋势分析

  • 非血管支架市场占有率（按地区），2023 年和 2030 年，十亿美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic
    • BD
    • Boston Scientific Corporation
    • ELLA-CS, sro
    • CONMED Corporation
    • HOBBS MEDICAL, INC
    • Cook
    • TAEWOONG
    • Glaukos Corporation
简介目录
Product Code: GVR-1-68038-663-9

Non-vascular Stents Market Growth & Trends:

The global non-vascular stents market size is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in the adoption of minimally invasive surgeries across the world.

Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.

Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

Non-vascular Stents Market Report Highlights:

  • Biliary stents dominated the market in 2023 due to increasing occurrence of liver and bile duct diseases such as cholangiocarcinoma and gallstones resulting in a rising need for less invasive methods to deal with blockages.
  • The gastrointestinal stents segment is expected to register the highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus
  • North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with a high prevalence of gastrointestinal cancer in the U.S. & Canada.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Non-Vascular Stents Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Non-Vascular Stents Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Non-Vascular Stents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-Vascular Stents Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Gastrointestinal Stents
    • 4.3.1. Gastrointestinal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Biliary
    • 4.4.1. Biliary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Duodenal
    • 4.5.1. Duodenal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Colonic
    • 4.6.1. Colonic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Pancreatic
    • 4.7.1. Pancreatic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Esophageal Stents
    • 4.8.1. Esophageal Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Pulmonary (Airway) Stents
    • 4.9.1. Pulmonary (Airway) Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Silicone Airway
    • 4.10.1. Silicone Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.11. Metallic Airway
    • 4.11.1. Metallic Airway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.12. Urological Stents
    • 4.12.1. Urological Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Globe Non-Vascular Stents Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-Vascular Stents Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Ambulatory Care Centers (ACS)
    • 5.4.1. Ambulatory Care Centers (ACS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Globe Non-Vascular Stents Market: Regional Estimates & Trend Analysis

  • 6.1. Non-Vascular Stents Market Share, By Region, 2023 & 2030, USD Billion
  • 6.2. North America
    • 6.2.1. North America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. Italy
      • 6.3.4.1. Italy Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Denmark
      • 6.3.6.1. Denmark Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Sweden
      • 6.3.7.1. Sweden Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Norway
      • 6.3.8.1. Norway Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. China
      • 6.4.2.1. China Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. India Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Non-Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. BD
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Boston Scientific Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. ELLA - CS, s.r.o.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. CONMED Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. HOBBS MEDICAL, INC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cook
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. TAEWOONG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Glaukos Corporation
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives